The 12 closest competitors and alternatives to DeVoro Medical Inc. among medical devices & publishing companies — ranked by similarity to what DeVoro Medical Inc. actually does, not by market-cap band.
Subscribe to see DeVoro Medical Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Devoro Medical, Inc. is a medical device company developing a mechanical thrombectomy platform for peripheral interventions. The company has received strategic investment from Marlborough, Massachusetts-based Boston Scientific, which announced an agreement to acquire Devoro Medical.
DeVoro Medical Inc. is a medical devices & publishing company headquartered in United States. It has raised at least $32M across the 3 funding rounds on record. Its most recent funding round, Series A, raised $5.5M in December 2021. Xcout tracks 1 named person at DeVoro Medical Inc., including Mary Ann Cooke (Vice President, Life Sciences).
At least $32M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $5.5M | 1 named | |
| SEC Form D filing | $18M | — | |
| SEC Form D filing | $8.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to DeVoro Medical Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Medical Devices
Boston Scientific Corporation operates as a global medical technology firm, specializing in the design, production, and worldwide distribution of innovative medical devices tailored for various interventional specialties. The company's operations are strategically divided into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Through its MedSurg division, Boston Scientific provides critical diagnostic and therapeutic tools aimed at addressing conditions affecting the gastrointestinal and pulmonary systems, alongside a diverse portfolio of solutions for urological and pelvic health issues. The Rhythm and Neuro segment is dedicated to advanced cardiac rhythm management and neurological interventions. Its product offerings encompass implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy (CRT) defibrillators, and pacemakers (including CRT pacemakers), all complemented by remote patient monitoring platforms. This segment also delivers sophisticated technologies for assessing and treating cardiac rate and rhythm irregularities, featuring solutions such as 3-D mapping and navigation systems, various ablation and diagnostic catheters, intracardiac ultrasound catheters, and related accessories. In the neurological domain, it furnishes spinal cord stimulator systems for managing chronic pain, indirect decompression systems, and deep brain stimulation systems. Boston Scientific's Cardiovascular segment presents an extensive array of products focused on heart and vascular health. This includes cutting-edge interventional cardiology solutions like drug-eluting coronary stent systems for treating coronary artery disease, as well as percutaneous coronary intervention (PCI) instruments designed to tackle atherosclerosis. The segment further provides intravascular catheter-directed ultrasound imaging and fractional flow reserve (FFR) devices, applicable in coronary arteries, heart chambers, and peripheral vessels, in addition to structural heart therapies. Beyond this, the company supplies stents, balloon catheters, wires, and atherectomy systems for arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents for venous conditions; and a comprehensive suite of products for cancer treatment, including peripheral embolization devices, radioactive microspheres, various ablation systems (such as cryotherapy), and micro/drainage catheters. Established in 1979, the corporation maintains its headquarters in Marlborough, Massachusetts.
Medical Devices
FARAPULSE, Inc. is a medical technology company specializing in biotechnology and cardiovascular solutions, headquartered in Menlo Park, California, and subsequently acquired by Boston Scientific.
Medical Devices
AtheroMed, Inc. was a U.S. medical-device company that developed catheter-based atherectomy technology, including the Phoenix Atherectomy System, for removing plaque from peripheral arteries. Its products were intended for vascular and interventional physicians treating patients with peripheral arterial disease.
Medical Devices
Xlumena, Inc. was a venture-backed medical device company that developed, manufactured, and sold minimally invasive, image-guided therapeutic endoscopy products for gastrointestinal procedures. In 2015, the San Diego-based company was acquired by Boston Scientific.
Medical Devices
Abiomed is a company that provides advanced medical technology and equipment. It was acquired by Johnson & Johnson and is headquartered in Danvers, Massachusetts.
Medical Devices
CardioFocus, Inc. is a medical device company headquartered in Marlborough, Massachusetts. The firm is dedicated to advancing ablation treatment for cardiac arrhythmias.
Medical Devices
Neuravi is a medical device company based in Galway, Ireland, that developed a clot-retrieving device designed to treat patients with acute ischemic stroke by removing lodged blood clots. Founded in 2009, the company was subsequently acquired by Johnson & Johnson's Codman Neuro unit.
Medical Devices
B-Balloon Ltd. is an Israel-based medical device company established in 2003 that provides devices and technologies to treat ostial and bifurcation lesions, including stents and stent delivery systems. The company was incubated by Peregrine Ventures and was later acquired by Medical Ventures Corp.
Medical Devices
Innova Vascular, Inc. is a medical device company based in Irvine, California, engaged in the development of innovative minimally invasive vascular technologies such as the Laguna Thrombectomy System.
Medical Devices
Embolx, Inc. is a medical equipment manufacturing company located in Sunnyvale, California, recognized as a leader in advanced microcatheter technology for targeted embolization procedures.
Medical Devices
Biosense Webster is a Johnson & Johnson MedTech company that develops cardiac electrophysiology technologies, including 3D electroanatomical mapping systems and catheter-based ablation tools. Its products are used by cardiologists and electrophysiologists to diagnose and treat heart-rhythm disorders such as atrial fibrillation.
Medical Devices
VVT Med Inc. develops minimally invasive, catheter-based medical devices designed for the treatment of various venous pathologies, including varicose veins. The company's proprietary products, such as ScleroSafe and V-Block, utilize mechanochemical technology to provide precise, non-thermal, and in-office vein closure treatments for patients.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for DeVoro Medical Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →